What is Protocol Link?
Protocol Link operates as a specialized consultancy focused on Good Manufacturing Practice (GMP) compliance and regulatory affairs for the pharmaceutical, medical device, and diagnostic sectors. With a legacy spanning nearly three decades, the firm provides high-impact solutions including quality systems development, project management, and comprehensive regulatory strategy. Having successfully executed over 986 projects across 27 countries, Protocol Link serves as a vital partner for companies navigating the rigorous demands of FDA oversight and international quality standards. Their market position is defined by deep technical expertise and a proven ability to align regulatory compliance with broader corporate business objectives.
How much funding has Protocol Link raised?
Protocol Link has raised a total of $723K across 2 funding rounds:
Debt
$350K
Debt
$373K
Debt (2020): $350K with participation from PPP
Debt (2021): $373K led by PPP
Key Investors in Protocol Link
PPP
Public-Private Partnership
What's next for Protocol Link?
With the recent influx of capital, Protocol Link is positioned to accelerate its enterprise-level service expansion. The firm is expected to prioritize the enhancement of its digital compliance management platforms and the broadening of its global footprint to meet the increasing demand for sophisticated regulatory navigation. As the life sciences sector faces heightened scrutiny and evolving international standards, Protocol Link's strategic roadmap involves deepening its bench of subject matter experts and investing in proprietary quality management frameworks. This approach ensures that the firm remains at the forefront of the industry, providing the necessary stability and strategic foresight for clients operating in high-stakes, regulated environments.
See full Protocol Link company page
